Induction of cyclo-oxygenase-2 mRNA by prostaglandin E2 in human prostatic carcinoma cells
1997

Prostaglandin E2 and Its Role in Prostate Cancer Cell Growth

publication Evidence: moderate

Author Information

Author(s): RR Tjandrawinata, R Dahiya, M Hughes-Fulford

Primary Institution: University of California, San Francisco

Hypothesis

The study investigates the effects of exogenous dimethylprostaglandin E2 (dmPGE2) on prostate cancer cell growth and COX-2 expression.

Conclusion

The study concludes that dmPGE2 increases prostate cancer cell growth and COX-2 mRNA levels, suggesting a role for PGE2 in maintaining cancer cell proliferation.

Supporting Evidence

  • Administration of dmPGE2 significantly increased cellular proliferation in PC-3 cells.
  • DmPGE2 also increased COX-2 mRNA levels in a time- and dose-dependent manner.
  • Flurbiprofen inhibited the up-regulation of COX-2 mRNA and PC-3 cell growth.

Takeaway

This study shows that a substance called PGE2 helps prostate cancer cells grow, and stopping it can slow down their growth.

Methodology

The study used human prostatic carcinoma PC-3 cells and measured cell growth, DNA content, and COX-2 mRNA levels in response to dmPGE2 treatment.

Statistical Information

P-Value

0.0008

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication